PDL BioPharma, Inc. Deferred Revenue
PDL BioPharma, Inc. had Deferred Revenue of $959.00 thousand as of 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2021-03-29
- 2019-12-31: Deferred Revenue $959.00K; Deferred Revenue as first filed $3.91M.
- 2018-12-31: Deferred Revenue $1.04M; Deferred Revenue as first filed $8.81M.
- 2017-12-31: Deferred Revenue $9.74M.
- 2016-12-31: Deferred Revenue $0.00.
| Period end | Deferred Revenue | Deferred Revenue as first filed |
|---|---|---|
| 2019-12-31 | $959.00K 10-K · filed 2021-03-29 | $3.91M 10-K · filed 2020-03-11 |
| 2018-12-31 | $1.04M 8-K · filed 2020-06-29 | $8.81M 10-K · filed 2019-03-15 |
| 2017-12-31 | $9.74M 10-K · filed 2019-03-15 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 | |
| 2015-12-31 | $87.00K 10-K · filed 2016-02-23 | |
| 2014-12-31 | $0.00 10-K · filed 2016-02-23 | |
| 2011-09-30 | $1.71M 10-Q · filed 2011-11-09 | |
| 2010-12-31 | $1.71M 10-Q · filed 2011-11-09 |